Date | Title | Description | Source |
23.04.2024 | Endo, Inc. Completes Acquisition of Endo International plc's... | Newly Formed Company Poised for Sustained Growth With a Strengthened Balance Sheet, Resolved Litigat... | salamancap... |
11.04.2024 | Endo, Inc. Announces Pricing of $1.5 billion of Senior Secur... | MALVERN, Pa., April 11, 2024 /PRNewswire/ -- Endo, Inc. ("Endo"), a newly formed entity, t... | salamancap... |
04.04.2024 | Lupin appoints Dr Ranjana Pathak as Chief Quality Officer | Drugmaker Lupin Limited has appointed Dr Ranjana Pathak as Chief Quality Officer, succeeding Johnny ... | thehindubu... |
01.04.2024 | Endo, Inc. Announces Proposed New Senior Secured Credit Faci... | MALVERN, Pa., April 1, 2024 /PRNewswire/ -- Endo, Inc. ("Endo"), a newly formed entity, to... | salamancap... |
05.03.2024 | Strides Pharma receives USFDA approval for neurology medicat... | Strides Pharma Science Limited (Strides) has received approval of Gabapentin Tablets USP, in strengt... | business-s... |
04.03.2024 | Biopharmaceutical Innovations Lead the Way in Migraine Drugs... | Migraine is a clinical condition associated with painful headaches and other symptoms such as nausea... | einpresswi... |
13.03.2023 | Endo Provides Top-Line Results from Phase 2 Study of Collage... | DUBLIN, March 13, 2023 /CNW/ -- Endo International plc ENDPQ today announced top-line results from i... | einpresswi... |
25.10.2021 | Endo International : Announces First-Ever XIAFLEX® (collagen... | DUBLIN, Oct. 25, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today the laun... | marketscre... |
10.09.2021 | Endo Settles New York State Opioid Cases and Provides Update... | Endo International plc announced that it and its wholly-owned subsidiaries, Endo Health Solutions In... | aithority.... |
04.08.2021 | Endo Announces Execution of Definitive Settlement Agreement ... | | prnewswire... |
22.07.2021 | Endo Announces Agreement in Principle to Settle Tennessee St... | | prnewswire... |
06.05.2021 | ENDO INTERNATIONAL PLC
Endo International : Reports First-Q... | DUBLIN, May 6, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial r... | marketscre... |
13.04.2021 | Endo Announces Publication of Phase 3 Qwo® (collagenase clos... | | prnewswire... |
11.03.2021 | Endo International plc Announces Pricing of Private Offering... | | prnewswire... |
11.03.2021 | Endo International plc Announces Proposed Private Offering O... | | prnewswire... |
05.01.2021 | Endo Announces Licensing Agreement for Paladin Labs Inc. to ... | | prnewswire... |
18.11.2020 | Endo Announces Expiration Of Hart-Scott-Rodino Waiting Perio... | | prnewswire... |
05.11.2020 | Endo Announces Strategic Actions to Further Position the Com... | | prnewswire... |
19.10.2020 | Endo to Acquire BioSpecifics to Enhance Profitability of XIA... | | prnewswire... |
05.07.2017 | Advent International to Buy SOMAR for $124M | Endo International plc (NASDAQ: ENDP) today announced it has entered into a definitive agreement to ... | citybizlis... |
05.07.2017 | Advent International to Buy SOMAR for $124M | Endo International plc (NASDAQ: ENDP) today announced it has entered into a definitive agreement to ... | archive.ci... |
31.03.2016 | FTC sues Endo Pharmaceuticals for paying off generic drugmak... | These kinds of settlements “harm consumers twice,” FTC Chairwoman Edith Ramirez said in a statement.... | medcitynew... |
23.04.2014 | Frenzy of pharma deals resembles 2008, but goal is leaner, m... | Between Pfizer and AstraZeneca deal rumors followed by a strategic portfolio exchange by GlaxoSmithK... | medcitynew... |
19.02.2014 | Endo Health takes $500M writedown on American Medical System... | Endo Health Solutions (NSDQ:ENDP) said today that it plans to write down the value of its American M... | massdevice... |
07.01.2014 | Cambridge Endo closes $3M round | Cambridge Endoscopic Devices closed a debt and options offering after meeting it $2.9 million target... | massdevice... |
05.12.2012 | How to solve the puzzle of end-to-end care? Just ask Endo He... | “There is no growth in duplication,” McHugh said. “Growth is in the gaps where patient need and comp... | medcitynew... |
02.10.2012 | Early stage companies join Philly life science and tech vent... | Steve Case, the former CEO and co-founder of AOL and founder of investment firm Revolution, will be ... | medcitynew... |
24.07.2012 | Chronic pain drug developer for cancer, lower back pain rais... | Location: Blue Bell, Pennsylvania
Industry: Pharmaceuticals
Solution/product: Its lead product is ch... | medcitynew... |
17.07.2012 | Par Pharmaceuticals’ generic appeal attracts $1.9 billion pr... | There has been quite a bit of crossover between generic and branded pharmaceutical companies with th... | medcitynew... |
04.05.2012 | 7 things to consider for your company’s social media policy... | Plan for a crisis. You will have one. Companies need to develop social media policies in order to be... | medcitynew... |
17.04.2012 | Patent award to BDSI triggers $15M milestone payment from En... | The USPTO had signaled earlier this year that it would issue a patent for the technology. In Februar... | medcitynew... |
16.02.2012 | BDSI to get patent; issuance triggers $15M milestone from pa... | The milestone payment will be coming from drug partner Endo Pharmaceuticals (NASDAQ:ENDP). Raleigh, ... | medcitynew... |
06.02.2012 | $40M stock offering filed by BioDelivery Sciences Internatio... | The Endo deal, which gave BDSI $30 million up front, secures a partner responsible for the phase 3 t... | medcitynew... |
14.11.2011 | Endo Pharmaceuticals ends development of drug for growth hor... | Additionally, Endo discontinued development of the octreotide implant for the treatment of carcinoid... | medcitynew... |
22.06.2011 | Endo closes the deal with American Medical Systems for $2.9 ... | Endo Pharmaceuticals Holdings Inc. (NSDQ:ENDP), once devoted solely to the drug market, began its fo... | massdevice... |
04.04.2011 | Invacare hires chief compliance officer | The company stressed at the time that it fully stands behind the safety of its products. “The FDA wa... | medcitynew... |
09.12.2009 | Shop Talk: Interphase Systems CEO John Biglin on Ready-IT Bi... | A year ago, John Biglin, the CEO of Interphase Systems, was talking to the CFO of an emerging Center... | technical.... |
- | 7 things to consider for your company’s social media policy... | Pharmaceutical and medical device companies seem to view social media with the alternating fascinati... | medcitynew... |
- | Frenzy of pharma deals resembles 2008, but goal is leaner, m... | Between Pfizer and AstraZeneca deal rumors followed by a strategic portfolio exchange by GlaxoSmithK... | medcitynew... |
- | Patent award to BDSI triggers $15M milestone payment from En... | A drug delivery technology patent awarded to BioDelivery Sciences International (NASDAQ:BDSI) has tr... | medcitynew... |
- | Par Pharmaceuticals’ generic appeal attracts $1.9 billion pr... | Generics producer Par Pharmaceuticals (NYSE: PRX) has been snapped up by a global private equity fir... | medcitynew... |
- | Endo Pharmaceuticals ends development of drug for growth hor... | Endo Pharmaceuticals (NASDAQ:ENDP) has ended its developments of an octreotide implant to treat a di... | medcitynew... |
- | Early stage companies join Philly life science and tech vent... | A long-running venture investment summit in Philadelphia will include presentations from early stage... | medcitynew... |
- | FTC sues Endo Pharmaceuticals for paying off generic drugmak... | It’s a lucrative thought to a drugmaker with branded drugs and patent-based revenues: Pay off encroa... | medcitynew... |
- | BDSI to get patent; issuance triggers $15M milestone from pa... | BioDelivery Sciences International (NASDAQ:BDSI) stands to gain a $15 million milestone payment afte... | medcitynew... |
- | Invacare hires chief compliance officer | Home health equipment maker Invacare (NYSE:IVC) has hired a chief compliance officer who previously ... | medcitynew... |
- | How to solve the puzzle of end-to-end care? Just ask Endo He... | They say knowing is half the battle.
Recognizing these three mantras was the first step that helped ... | medcitynew... |
- | $40M stock offering filed by BioDelivery Sciences Internatio... | A month after licensing a clinical-stage chronic pain treatment to Endo Pharmaceuticals (NASDAQ:ENDP... | medcitynew... |
- | Chronic pain drug developer for cancer, lower back pain rais... | Company name: Relmada Therapeutics
Location: Blue Bell, Pennsylvania
Industry: Pharmaceuticals
Solut... | medcitynew... |